felodipine has been researched along with losartan potassium in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Ni, Z; Vaziri, ND; Wang, XQ | 1 |
| Vaziri, ND; Wang, XQ | 1 |
3 other study(ies) available for felodipine and losartan potassium
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Nitric oxide metabolism in erythropoietin-induced hypertension: effect of calcium channel blockade.
Topics: Animals; Blood Pressure; Blotting, Western; Calcium; Calcium Channel Blockers; Drug Interactions; Erythropoietin; Felodipine; Hypertension; Kidney Failure, Chronic; Male; Nephrectomy; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Vasodilator Agents | 1998 |
Erythropoietin depresses nitric oxide synthase expression by human endothelial cells.
Topics: Acetylcholine; Calcium Channel Blockers; Cell Division; Cells, Cultured; Down-Regulation; Endothelium, Vascular; Erythropoietin; Felodipine; Humans; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III | 1999 |